# Children's Hospital Los Angeles (CHLA) account plan

> Children's Hospital Los Angeles is a not-for-profit pediatric academic hospital in Los Angeles County with $1,885.7 million of FY2025 revenues.

## At a glance

Children's Hospital Los Angeles (CHLA) is a not-for-profit corporation operating a children's hospital and pediatric ambulatory services in Los Angeles County, focused on tertiary and quaternary pediatric care, research and education. It is affiliated with the Keck School of Medicine of USC and, per Moody's, has six special care centers across Southern California and over 80 locations in its care network. In fiscal 2025 (year to June 30, 2025) total revenues were $1,885.7 million, with a deficit of revenues over expenses of $(47.1) million. Medi-Cal patients made up 68.9% of net patient service revenue.

## Business units

- **Hospital (program services)** (about 70.5% of FY2025 total expenses ($1,363.4 million)): Inpatient, outpatient, emergency and physician services for children in Los Angeles County, funded mainly by net patient service revenue of $1,403.7 million in FY2025, of which Medi-Cal $503.7 million and managed care $404.9 million. Physician practice runs through the unconsolidated CHLA Medical Group.
- **Research and Education** (about 9.6% of FY2025 total expenses ($186.4 million)): Research and graduate medical training, with grants, contracts and other revenue of $241.3 million in FY2025 and federal award expenditures of $75.4 million. Affiliates include the USC/CHLA Cell Therapy Collaborative and the VPS pediatric ICU benchmarking database.
- **Management and General** (about 18.6% of FY2025 total expenses ($359.2 million)): Support services including information technology and finance, plus real-estate holding entities that hold properties for future expansion of CHLA.
- **Fundraising (philanthropy)** (about 1.2% of FY2025 total expenses ($23.8 million)): Foundation staff soliciting grants and private donations; total endowment and board-designated funds were $816.5 million at June 30, 2025.

## Strategic priorities

- **Restore liquidity**: After days cash on hand fell to approximately 17 by Dec. 31, 2025, CHLA issued $187.5 million in taxable revenue bonds in March 2026, with a Series 2026B issue of an equivalent amount expected, to lift days cash to 54 or above 60.
- **Performance improvement**: Management's fiscal 2026 focus includes labor-related savings and revenue cycle enhancements, targeting a 2% operating cash flow margin for the year.
- **Secure state supplemental funding**: The California Hospital Fee Program and Children's Hospital Supplemental Payment Program were 29.3% of net patient service revenue in FY2025; the delayed CMS approval of round nine is a major factor in the liquidity strain.
- **Pediatric research and training**: CHLA underwrote $24.8 million of research costs and $19.1 million of training costs in FY2025 and runs numerous residency and training programs.

## Latest results

No fiscal 2026 financial statements are in the documents. According to Moody's, as reported by The Bond Buyer on March 30, 2026, second-quarter fiscal 2026 results improved on the first quarter, with a year-to-date operating cash flow margin of 1.1%, against a 2% target for the year. Days cash on hand dropped to approximately 17 by Dec. 31. Moody's cut CHLA to Ba2 on March 5 with a negative outlook, citing challenged operations and very weak liquidity.

## Investments and deals

- **2026 taxable bond financing**: $187.5 million of taxable revenue bonds issued in March 2026, insured by Assured Guaranty; Moody's estimates roughly $774 million of debt outstanding after Series 2026B.
- **2025 refinancing**: On March 1, 2025 CHLA issued $135.8 million Series 2025A and $150.0 million Series 2025B revenue bonds, retiring earlier series and terminating a bank line and an interest rate swap.
- **Facilities and expansion**: Property and equipment acquired was $70.5 million in FY2025 and construction in progress reached $155.9 million; CHLA received $33.5 million under the Children's Hospital Bond Act of 2018.

## Challenges and risks

- **Very weak liquidity**: Days cash on hand fell from 136 at June 30, 2025 to approximately 17 by Dec. 31, 2025; Moody's rates CHLA Ba2 with a negative outlook.
- **Medi-Cal dependence**: Medi-Cal was 68.9% of net patient service revenue in FY2025, and the unpaid cost of Medi-Cal programs was $539.5 million.
- **Operating deficits**: CHLA ran a deficit of revenues over expenses for two years running: $(47.1) million in FY2025 after $(77.7) million in FY2024.
- **Rising costs**: Salaries and employee benefits rose to $999.6 million and supplies to $289.8 million in FY2025.
- **Cyber and vendor risk**: After the February 2024 Change Healthcare attack CHLA took Optum temporary funding, of which $11.5 million remained a liability at June 30, 2025.

## Where a supplier can help

- **Revenue cycle improvement**: Tied to the performance improvement priority: revenue cycle enhancements are an explicit management focus for fiscal 2026.
- **Labor productivity**: Tied to the performance improvement priority and rising costs: labor-related savings through staffing, scheduling and workforce tools.
- **Cash and working capital management**: Tied to the liquidity challenge: tools that speed collection of state program and payer receivables.
- **Cybersecurity and vendor resilience**: Tied to the cyber and vendor risk challenge after the Change Healthcare attack.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Children's Hospital Los Angeles - Consolidated Financial Statements as of and for the Years Ended June 30, 2025 and 2024, and Uniform Guidance Single Audit Report](https://app.fac.gov/dissemination/report/pdf/2025-06-GSAFAC-0000393748)

Annual report · 2025-11-26

- Children's Hospital Los Angeles (CHLA) is an independent not-for-profit corporation operating a children's hospital and pediatric ambulatory services in Los Angeles County, focused on "tertiary and quaternary specialties in patient care, research, and education"; FY ends June 30; auditor's opinion unmodified (report dated November 26, 2025).
- FY2025 total revenues $1,885.7 million (FY2024: $1,740.7 million); net patient service revenue $1,403.7 million, of which Hospital Fee Program revenue $357.8 million and a new Children's Hospital Supplemental Payment Program $53.5 million; grants, contracts and other $241.3 million.
- Still loss-making: deficit of revenues over expenses of $(47.1) million after depreciation and interest, and $(23.7) million after investment gains (FY2024: $(77.7) million and $(63.0) million). Net assets fell $87.4 million to $1,599.6 million.
- Medi-Cal dependence is the defining risk: Medi-Cal patients were 68.9% of net patient service revenue (56% excluding the Hospital Fee Program); the Hospital Fee Program and supplemental program were 29.3%; unpaid cost of Medi-Cal programs $539.5 million (unaudited), up from $306.2 million.
- Expenses $1,831.2 million before depreciation, amortization and interest: salaries and benefits $999.6 million, professional fees and purchased services $338.8 million, supplies $289.8 million.
- Liquidity tightened: days cash on hand 136 (164 a year earlier); cash and equivalents $36.7 million vs $106.0 million; net cash used in operating activities $(179.6) million.
- Refinancing: $135.8 million Series 2025A and $150.0 million Series 2025B variable-rate revenue bonds issued March 1, 2025 to retire the 2022A and 2017B bonds and a $50 million line of credit; long-term debt net of current portion $560.3 million; covenant of 1.10x debt service coverage met.
- Capex: $70.5 million of property and equipment acquired; construction in progress $155.9 million; Proposition 4 (Children's Hospital Bond Act of 2018) paid $33.5 million in FY2025.
- Research: federal awards expenditures $75.4 million, of which the Research and Development Cluster $62.1 million; no audit findings, low-risk auditee.

### [The Bond Buyer: Children's Hospital Los Angeles bond deals expected to increase liquidity](https://www.bondbuyer.com/news/childrens-hospital-los-angeles-bonds-expected-to-improve-liquidity)

Report · 2026-03-30

- The Bond Buyer (March 30, 2026): CHLA issued $187.5 million of taxable revenue bonds; BofA Securities priced the $185.7 million Series A on March 25 at a 5.4% coupon, yield +137 to Treasuries.
- Moody's affirmed CHLA at junk Ba2 with a negative outlook, citing "challenged operations, and very weak liquidity" and heavy reliance on state funding through its Medicaid exposure.
- Credit slide: Moody's cut CHLA to Ba1 from investment grade Baa3 in December, then to Ba2 on March 5; S&P downgraded it to BB-plus from BBB-minus on Feb. 25, 2025 and withdrew the rating in October.
- Days cash on hand fell to about 17 by Dec. 31; the financing was expected to lift it to 54 days (above 60 days in another passage). Delay of CMS approval of round nine of California's provider fee program is a major cause.
- A Series 2026B issue of an equivalent amount was expected within 60 days; Moody's estimates about $774 million of debt outstanding afterwards.
- Management's fiscal 2026 priorities: labor-related savings and revenue cycle enhancements; year-to-date operating cash flow margin 1.1% after the second quarter, target 2% for the year.
- Bonds insured by Assured Guaranty (A1 Moody's, AA S&P); nearly $500 million of restricted investments support operations, capital and research.

## Questions about Children's Hospital Los Angeles (CHLA)

### What does Children's Hospital Los Angeles do?

CHLA operates a not-for-profit children's hospital and pediatric ambulatory services in Los Angeles County, providing high-acuity pediatric care, research and medical training, affiliated with the Keck School of Medicine of USC.

### What is Children's Hospital Los Angeles' revenue?

Total revenues were $1,885.7 million in fiscal 2025 (year to June 30, 2025), up from $1,740.7 million.

### What is CHLA's financial situation?

It ran operating deficits in FY2024 and FY2025, and days cash on hand fell to approximately 17 by Dec. 31, 2025; it issued $187.5 million of taxable bonds in March 2026 to rebuild liquidity.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
